.png)
How AXC
Funds Trials
Capital is raised for one trial, released only as each milestone is verified,
and reported back from live trial data on Ecosera
.png)
Investors
Provide capital via RWA tokens
Trial SPV (RWA)
Economic rights in one trial
Biotech / Researchers
Milestone-based research
AXC Treasury
Holds value, regenerates capital
Compassionate-Use
Mission-driven reinvestment
Community
Platform governance
Investors
Provide capital via RWA tokens
Trial SPV (RWA)
Economic rights in one trial
Biotech / Researchers
Milestone-based research
AXC Treasury
Holds value, regenerates capital
Compassionate-Use
Mission-driven reinvestment
Community
Platform governance
The Four-Step Value Loop
Each step feeds into the next, creating a sustainable cycle of innovation and growth
Stake AXC
Platform Governance
Stake AXC to vote on material platform changes and elect an investor representative. Funding decisions sit with an expert committee, not token votes. AXC carries no equity, ownership or profit rights.
Fund One Trial
Trial-Specific SPVs
Accredited investors finance one trial at a time through a trial-specific SPV (Reg D 506(c) / Reg S). Capital is held in escrow until milestones are met.
Verified Milestones
Release on Evidence
An expert scientific and investment committee selects programs. Tranches are released only when an independent verifier confirms a milestone from Ecosera's trial evidence.
Trial Economics
RWA Holders
RWA holders receive a tiered royalty on the molecule and a capped share of licensing or exit proceeds. Unreleased tranches return to investors if a trial stops.
Three-Layer Token
Architecture
Purpose-built on Cardano. Governance, operations, and trial economics, each with a distinct token role.
AXC (AxellaCoin)
Platform governance: holders vote on material changes and elect an investor representative. Funding decisions sit with an expert committee, and releases follow verified milestones, not votes. AXC carries no equity, ownership or profit rights.
- •1B fixed supply
- •Governance & utility
- •Elects an investor representative
- •No equity, ownership or profit rights
AXUSD (Operations Stablecoin)
USD-pegged stablecoin for all platform payments: CRO bids, site payments, vendor invoices, and patient stipends. Every payment reconciles to a milestone.
- •1:1 USD peg for stability
- •Milestone-based trial and site payments
- •Vendor invoices and patient stipends
- •Transparent, auditable flows
RWA (Trial Economics)
Economic rights in one funded trial through a trial-specific SPV: a tiered royalty on the molecule (full rate in the funded indication, reduced in follow-on indications) and a share of licensing or exit proceeds, capped at a multiple. Unreleased tranches return to investors if a trial stops.
- •Trial-specific SPV
- •Tiered royalty on the molecule
- •Capped share of licensing or exit proceeds
- •Accredited investors only (Reg D 506(c) / Reg S)
The AxellaCoin trial-financing model described here is in development and not yet available. Royalty and return terms are set per trial in its offering documents. Nothing on this site is an offer to sell, or a solicitation of an offer to buy, any security or token.
Stable, Compliant
Payment Rails
Vendor and trial payments via AXUSD, our USD-pegged stablecoin for clinical research.
Predictable Payments
USD-pegged stability eliminates volatility for vendors and researchers
Clean Accounting
Simplified tax reporting and transparent tracking
Auditable Flows
On-chain transparency for every transaction
How It Works
Trial Funding Approved
Milestone-based payments in AXUSD
Vendors Get Paid
Stable USD-equivalent payments to CROs and labs
Pioneer Rewards
Optional AXC acceptance for ecosystem alignment
1:1 USD Peg: Reserve-backed for stable value.
New Era for
Clinical Funding
Dual structure balancing profit-driven growth with mission impact
Axella Treasury
For-Profit Entity
- •Holds RWA proceeds and exit gains
- •Manages reinvestment into new trials
- •Operates under governance policy
Axella Foundation
Non-Profit Entity
- •Deploys compassionate-use grants
- •Vets trials for scientific rigor
- •Supports open-science initiatives
Join the
Ecosystem
Multiple pathways to participate in the future of clinical research
Investors
Economic rights in one funded trial through a trial-specific SPV. Accredited investors only.
Explore RWA TokensTrial Pipeline
Illustrative projects; replace with live listings. Eligibility depends on jurisdiction and KYC.
Pancreatic Cancer
Targeting KRAS G12D; endpoints: PFS/OS with 12-month follow-up
Alzheimer's Discovery
Novel small-molecule modulating microglial activation; IND-enabling studies
DMD Gene Therapy
AAV9 delivery for dystrophin restoration; safety/PK primary endpoints
Transparency Dashboard
Real-time on-chain metrics via Blockfrost API
Live data sourced from on-chain at launch
Governance
Three-Layer System
Transparent decision-making at every level
Community Governance (AXC)
AXC token holders participate in key ecosystem decisions
- •Vote on material platform changes
- •Elect an investor representative
- •Propose ecosystem improvements
- •Funding decisions sit with an expert committee
Stake & Support
Exclusive Benefits
Access community resources and exclusive content by staking AXC tokens
AMA with Lead Researcher
Monthly sessions with PIs leading funded trials
Biotech Investing 101
Educational webinars on clinical trial economics
Private Supporter Cohort
Exclusive Discord for AXC stakers
Community Bounties
Earn rewards for content creation and outreach
Milestone Showcase Events
Quarterly virtual events celebrating trial progress
Early & Gated Information
Pre-announcement access to new trial opportunities
Meet the Team Behind
AxellaCoin
Core Team
Avi Kamelhar
Founder & CEO
Seasoned entrepreneur and technology leader with extensive experience in blockchain, DeFi, and healthcare innovation. Avi brings a unique blend of business acumen and technical expertise to drive AxellaCoin's vision of democratizing medical research funding.
Henry Hazan
CTO & Co-Founder
Expert blockchain architect and full-stack developer with deep expertise in smart contract development, tokenomics, and decentralized systems. Henry leads the technical architecture and implementation of the AxellaCoin ecosystem.
Medical Advisors
Judd Boczko, MD
Medical Advisor
- •Board-certified urologist with 25+ years clinical experience
- •Specializes in robotic and minimally invasive treatments
- •Led multiple clinical trials
- •Chief Investment Officer at Overlook Research & Investments
- •Reviews grant proposals and guides trial strategy
Our Journey to
Revolutionize Funding
Platform Development
Q4 2025
Building smart contracts, governance mechanisms, and user interfaces
Platform Launch
Q1 2026
Launch AXC token on Cardano and open platform to researchers
First Clinical Trials
Q2 2026
Fund first compassionate use protocols, selected by the expert scientific and investment committee
Staking Rewards & Airdrops
Future phase
Staking rewards and community airdrops for AXC holders, subject to legal review. Funded from the AXC treasury, not from trial royalties or proceeds
Global Expansion
Q4 2026
Expand to support institutions in Europe and Asia
The Operating PlatformPowered by
ecosera
AXC tokens fuel the economy. ecosera runs the operations. The complete clinical trials operating system where every stakeholder — Sponsors, CROs, Sites, Vendors, Patients, and Investors — collaborates on a single unified platform.
Study Management
End-to-end trial operations — from RFP to closeout, across Sponsors, CROs, Sites, and Vendors.
AXUSD Payments
Milestone-based payments, patient stipends, and vendor invoicing — all settled in AXUSD stablecoin.
Regulatory & TMF
ICH GCP E6(R3) compliant document management, eCTD submissions, and inspection readiness.
21 CFR Part 11 Signatures
AI-powered e-signatures with SHA-256 hashing, multi-signer flows, and full audit trails.
Patient Portal & PHR
FHIR R4 health records, trial matching, family sub-portals, and research consent management.
Analytics & Monitoring
Risk-based monitoring, enrollment analytics, budget burn rates, and site compliance scoring.
.png)
Legal Disclaimer
Important information about token structure, compliance, and regulatory framing
Token Classification
AXC (AxellaCoin) - Governance & Utility Token
AXC is the governance and utility token of the AxellaCoin / ecosera ecosystem (1B fixed supply). Holders vote on material platform changes and elect an investor representative; funding decisions sit with an expert committee, and releases follow verified milestones, not votes. AXC does not represent equity, ownership, or profit rights.
RWA (Trial Economics) - Securities Token
RWA tokens carry economic rights in one funded clinical trial through a trial-specific SPV: a tiered royalty on the molecule and a capped share of licensing or exit proceeds, with unreleased tranches returned if a trial stops. They are offered under Reg D 506(c) in the US and Reg S internationally, to accredited investors only. This is a regulated security offering, separate from AXC.
AXUSD - Stablecoin Payment Rail
AXUSD is a USD-pegged stablecoin used for platform payments: CRO bids, site payments, vendor invoices, and patient stipends. It provides stable, predictable payment flows with transparent on-chain tracking.
Utility Purposes Only:
- •Support for trial funding initiatives
- •Staking for platform participation
- •Access to CRO services (future phase)
- •Platform governance (material changes, investor representative)
When AXC is used to fund biotech startups, any resulting equity, warrants, or royalties are held by Axella Research or an affiliated treasury. These assets are not distributed to token holders, but may be used to reinvest in future research.
This structure enables a sustainable funding ecosystem—not a profit-sharing scheme.
The value of AXC may fluctuate. By using AXC, you acknowledge that it is a utility token, not a financial instrument, and is used at your own discretion. The trial-financing model described on this site is in development and not yet available; nothing here is an offer to sell, or a solicitation of an offer to buy, any security or token.